GSTC (GlobeStar Therapeutics) Tariff Resilience Score: 0/10 (As of Jun. 30, 2026)


What is GlobeStar Therapeutics Tariff Resilience Score?

GlobeStar Therapeutics has the Tariff Resilience Score of 0, which implies that the company might have .

GlobeStar Therapeutics has GlobeStar Therapeutics has moderate tariff exposure, with some reliance on imported materials. The company has alternative supplier options and some pricing power, which have helped mitigate historical tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes GlobeStar Therapeutics might have .

GlobeStar Therapeutics  (OTCPK:GSTC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

GlobeStar Therapeutics Tariff Resilience Score Related Terms

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.